ClinicalTrials.Veeva

Menu

Propofol Versus Ketamine for Moderate Procedural Sedation in the Emergency Department (ED)

Hennepin Healthcare logo

Hennepin Healthcare

Status and phase

Completed
Phase 4

Conditions

Sedation

Treatments

Drug: propofol
Drug: Ketamine

Study type

Interventional

Funder types

Other

Identifiers

NCT00997321
MMRF062661

Details and patient eligibility

About

This study is a clinical trial of moderate sedation with propofol versus moderate sedation with ketamine for procedural sedation in the Emergency Department.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients who require moderate procedural sedation with propofol in the ED

Exclusion criteria

  • age > 17 years
  • pregnant
  • intoxicated
  • cannot give informed consent
  • allergy to ketamine or propofol
  • patient will require deep procedural sedation
  • ASA physical status score > 2

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Propofol
Active Comparator group
Description:
propofol 1 milligram per kilogram intravenous bolus followed by 0.5 millligrams per kilogram as needed for mooderate procedural sedation
Treatment:
Drug: propofol
Ketamine
Active Comparator group
Description:
ketamine 1 milligram per kilogram followed by 0.5 millgram per kilogram as needed for moderate procedural sedation
Treatment:
Drug: Ketamine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems